English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech HealthCare & Pharma
Hong Kong International Optical Fair opens in November
Oct 18, 2019 20:00 HKT
Malaysian Companies Develop Ingredients for World's First Healthy Bubble Tea
Oct 18, 2019 14:45 HKT
HOLISTA響應全球對糖尿病和肥胖症的擔憂 攜手合作夥伴開發全球首款健康泡泡茶配料組合
Oct 17, 2019 17:00 HKT
HOLISTA响应全球对糖尿病和肥胖症的担忧 携手合作伙伴开发全球首款健康泡泡茶配料组合
Oct 17, 2019 17:00 HKT
Holista Collaborates to Develop World's First Combined Suite of Healthybubble Tea Ingredients amidst Concerns of Diabetes and Obesity
Oct 17, 2019 17:00 HKT
德視佳國際眼科有限公司公佈於香港聯合交易所有限公司主板上市計劃詳情
Sep 30, 2019 07:00 HKT
EuroEyes International Eye Clinic Ltd announces proposed listing on HKEx Main Board
Sep 30, 2019 06:00 HKT
TransCanna Closes Acquisition of SolDaze
Sep 20, 2019 05:00 HKT
TransCanna Appoints Peter Vitulli Former President of Gatorade to the Board of Directors
Sep 17, 2019 21:30 HKT
复宏汉霖产线后续力量充沛 全球商业布局抢占市场份额
Sep 16, 2019 17:43 HKT
復宏漢霖產線後續力量充沛 全球商業佈局搶佔市場份額
Sep 16, 2019 17:42 HKT
TransCanna Signs Binding Agreement with Lyfted Farms Inc.
Sep 13, 2019 07:00 HKT
多款单抗产品「收获期」将至 复宏汉霖剑指海外拓展商机
Sep 12, 2019 10:43 HKT
多款單抗產品「收穫期」將至 復宏漢霖劍指海外拓展商機
Sep 12, 2019 10:42 HKT
知臨集團已啟動用於治療包括MRSA的金黃色葡萄球菌感染小分子候選藥物ALS-4的IND籌備研究
Sep 10, 2019 13:02 HKT
Aptorum Group has initiated IND-Enabling Studies for its ALS-4 Small Molecule Candidate for the Treatment of Infections Caused by Staphylococcus Aureus including MRSA
Sep 10, 2019 13:01 HKT
知臨集團宣布靶向肥胖症微生物組候選藥物和神經母細胞瘤再利用候選藥物的開發
Sep 10, 2019 12:37 HKT
Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma
Sep 10, 2019 12:36 HKT
TransCanna Announces Corporate Update
Sep 03, 2019 22:00 HKT
Azelis appoints Group Technical Innovation Director
Sep 04, 2019 16:00 HKT
Next >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: